Search the Newsreel

San Luis Wealth Advisors LLC Buys New Stake in Kenvue Inc. $KVUE

San Luis Wealth Advisors LLC recently acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing 52,880 shares valued at approximately $1.01 million. Kenvue's stock is largely held by institutional investors, owning 97.64% of the company, and analysts generally rate it as a "Hold" with …

Handelsbanken Fonder AB Has $21.75 Million Position in Kenvue Inc. $KVUE

Handelsbanken Fonder AB increased its stake in Kenvue Inc. (NYSE:KVUE) by 6.5% during the second quarter, bringing its total holdings to over 1.1 million shares valued at approximately $21.75 million. Other institutional investors also adjusted their positions in Kenvue, with notable increases from firms …

Brookstone Capital Management Sells 193,541 Shares of Kenvue Inc. $KVUE

Brookstone Capital Management significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 70.3% in the second quarter, selling 193,541 shares and retaining 81,929 shares valued at $1.57 million. This divestment occurred as Kenvue reported slightly lower-than-expected quarterly EPS of $0.31, missing the $0.32 consensus, …

Kenvue Stock And 2 Consumer Staples Picks For Defensive Dividend Investors

Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects

Kenvue Inc. KVUE, the world's leading pure-play consumer health company, delivered year-over-year improvement in second-quarter 2026, although earnings and sales slightly missed the respective Zacks Consensus Estimate. Net sales rose 3% year over year to $3.96 billion, while organic sales increased 1.6%. Kenvue's second-quarter …

RBC Capital Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)

RBC Capital maintained its Hold rating on Kenvue, Inc. (KVUE) with a $20.00 price target, while Canaccord Genuity also kept a Hold rating with an $18.00 target. Kenvue recently reported increased quarterly revenue and net profit. Insider sentiment for KVUE stock is negative, with …

KVUE Maintained by UBS -- Price Target Lowered to $19.00

UBS has lowered its price target for Kenvue Inc (KVUE) from $20.00 to $19.00 while maintaining a Neutral rating. Despite this, GuruFocus calculates KVUE's GF Value™ at $19.70, suggesting the stock is currently undervalued by 3.3%. The company, a consumer health leader with brands …

UBS Adjusts Kenvue Price Target to $19 From $20, Maintains Neutral Rating

UBS has adjusted its price target for Kenvue (KVUE) to $19 from $20, while maintaining a Neutral rating on the stock. This adjustment comes shortly after HSBC also revised its price target for Kenvue to $19 from $20, maintaining a Hold rating. The article …

Kenvue Inc (KVUE) Stock News Today

This article provides Kenvue Inc (KVUE) stock news, including its current stock price, market capitalization, and P/E ratio. It highlights the company's recent Q2 2026 earnings report, which showed increased sales and EPS despite narrowing margins. The page also offers various financial data, analyst …

Kenvue Inc. Stock 12‑Month Price Target Cut to $19.4, Implies 1% Upside

Kenvue Inc.'s average 12-month price target has been lowered from $19.5 to $19.4 by 10 analysts, with forecasts ranging from $18 to $22 per share. This updated target suggests a 1% potential upside from its August 7 closing price. The consensus rating for Kenvue …

HSBC Adjusts Price Target on Kenvue to $19 From $20, Maintains Hold Rating

HSBC has revised its price target for Kenvue (KVUE) to $19, down from the previous $20, while reaffirming a Hold rating on the stock. This adjustment comes amidst recent news including Kenvue's Q2 adjusted earnings and revenue rising, as well as the company missing …

Kenvue Q2: Skin Health & Beauty Net Sales Rise 5.1%

Kenvue reported strong Q2 2026 results with overall net sales up 3.0% and organic sales up 1.6%. The Skin Health & Beauty segment was a key driver, seeing a 5.1% increase in net sales, attributed to strong e-commerce performance, strategic execution, and innovations. The …

Jacobs & Co. CA Has $1.83 Million Stake in Kenvue Inc. $KVUE

Jacobs & Co. CA significantly reduced its stake in Kenvue Inc. by 45.7% in the second quarter, now holding 96,044 shares valued at $1.83 million. Despite missing analyst expectations for Q2 adjusted EPS and revenue, Kenvue's revenue increased by 3.0% year over year, and …

Wall Street Zen Downgrades Kenvue (NYSE:KVUE) to Hold

Wall Street Zen has downgraded Kenvue (NYSE:KVUE) from a "Buy" to a "Hold" rating, reflecting a consensus among analysts. The company's second-quarter revenue grew 3% year-over-year to $3.96 billion, but EPS and revenue slightly missed expectations due to inflationary pressures, tariffs, and currency costs. …

Kenvue Inc. $KVUE Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 49.8% in the second quarter, selling 3.19 million shares and retaining 3.22 million shares. This move comes as Kenvue reported Q2 sales of $3.96 billion and adjusted EPS of $0.31, both …

Kenvue (KVUE) Stock Holds Firm As Margin Gains Anchor The Story

Noticias de acciones de Kenvue Inc (KVUE)

Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Kenvue (KVUE) reported Q2 earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32, though it represents an increase from $0.29 per share a year ago. The company also missed revenue estimates, posting $3.96 billion against an expected $3.99 billion. Despite these …

Kenvue Earnings: Rare Volume Growth Despite Muted US and Europe Performance Impresses

Kenvue reported 3% revenue growth and 7% adjusted EPS growth in the second quarter, driven by 0.7% volume growth despite muted performance in the US and Europe. This volume growth was a rare achievement for the company. Morningstar highlighted this positive performance in their …

Kenvue Inc. (KVUE) Stock Forecasts

Kenvue Inc. (KVUE) is the world's largest pure-play consumer health company, having spun off from Johnson & Johnson in May 2023. Recent earnings show rare volume growth despite muted performance in the US and Europe. Analysts continue to evaluate its market position and financial …

Kenvue (NYSE:KVUE) Posts Earnings Results, Misses Expectations By $0.01 EPS

Kenvue (NYSE:KVUE) reported its quarterly earnings, missing analyst expectations by $0.01 EPS with $0.31 per share, against an estimated $0.32. The company's revenue of $3.96 billion also slightly missed the $3.97 billion forecast but marked a 3.0% increase year-over-year. Kenvue declared a quarterly dividend …

Press Release: Kenvue Reports Second Quarter 2026 Results

This document is a press release from Kenvue reporting their second quarter 2026 financial results. Without further content, the specific details of these results are unknown.

Kenvue Inc. stock falls Thursday, underperforms market

Kenvue Inc. (KVUE) stock fell by 2.49% on Thursday, closing at $19.18, and underperformed the broader market. This decline occurred during an overall poor trading session where the S&P 500 Index dropped 0.18% and the Dow Jones Industrial Average fell 0.85%. The stock's fall …

Kenvue Stock Falls 2.7% as Growth Arrives With Thinner Margins

This article first appeared on GuruFocus. Kenvue (NYSE:KVUE), the consumer-health giant behind Tylenol, Neutrogena and Listerine, delivered another quarter of steady growth, but that was not enough to keep investors happy as the stock slid about 2.7% on Thursday. Revenue climbed 3% year over …

KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise

Kenvue Inc. (KVUE) reported its Q2 2026 results, with both adjusted earnings and net sales missing Zacks Consensus Estimates despite showing increases year-over-year. The company experienced narrowing margins due to inflation and foreign exchange, while its Self Care segment returned to organic growth and …

Kenvue second quarter results fall short of expectations, sending shares lower

Kenvue Inc. (NYSE:KVUE) reported second-quarter results that fell slightly below Wall Street expectations, causing its shares to drop by about 2%. The consumer health company reported adjusted diluted earnings per share of $0.31 on revenue of $3.96 billion, missing analyst estimates of $0.32 EPS …

Market movers: Western Digital, Sandisk, Kenvue, Fiserv...

Fiserv, Kenvue, Western Digital, and Sandisk experienced declines due to lowered outlooks or missed expectations. Fiserv's shares fell over 3% after reducing its 2026 organic revenue forecast, while Kenvue's shares dropped 2% after missing Q2 earnings estimates. Western Digital and Sandisk both saw their …

FMR LLC discloses 8.2% Kenvue Inc. (KVUE) ownership in amended 13G filing

FMR LLC has filed an amended Schedule 13G, revealing a beneficial ownership of 8.2% in Kenvue Inc. (KVUE), amounting to 157,051,418.71 shares of common stock. The filing details FMR LLC's sole voting power over 107,583,737.47 shares and sole dispositive power over the full 157,051,418.71 …

Kenvue stock falls after earnings miss analyst estimates

Kenvue Inc. shares dropped in premarket trading after the company reported second-quarter results that missed Wall Street's earnings and revenue estimates. Despite the miss, Kenvue saw its third consecutive quarter of net and organic sales growth, with gains across all segments and regions, and …

Kenvue misses quarterly estimates as inflation, tariffs squeeze margins

Aug 6 (Reuters) - Kenvue narrowly missed Wall Street estimates for second-quarter results on Thursday as inflation, ‌tariffs and currency-related costs squeezed margins. The consumer-health ‌company, currently in the midst of a $40 billion buyout by Kimberly-Clark, ​expects the deal to close in the …

Kenvue incumple las previsiones trimestrales por la presión de la inflación y los aranceles sobre sus márgenes

Kenvue Posts Higher Profit, Sales as Turnaround Continues

Kenvue reported higher profit and sales in the second quarter, with net sales increasing 3% to $3.96 billion, slightly below Wall Street estimates. The company, known for products like Tylenol and Listerine, achieved a profit of $456 million, or 24 cents a share, up …

Earnings Flash (KVUE) Kenvue Inc. Posts Q2 Adjusted EPS $0.31 per Share, vs. FactSet Est of $0.32

Kenvue Inc. (KVUE) reported its Q2 adjusted earnings per share (EPS) of $0.31, which fell short of FactSet's estimate of $0.32. This financial update indicates that the company's Q2 performance did not meet analyst expectations for its adjusted EPS. The article is part of …